Extracorporeal Membrane Oxygenation (ECMO)

Subscribe to Selected New Research on Extracorporeal Membrane Oxygenation

1725 relevant articles (129 outcomes, 175 trials/studies) found for this Therapy

Description: Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure.

Also Known As:

ECMO; Extracorporeal Membrane Oxygenations; Membrane Oxygenation, Extracorporeal; Membrane Oxygenations, Extracorporeal; Oxygenations, Extracorporeal Membrane; Oxygenation, Extracorporeal Membrane

Relationship Network

Therapy Context: Research Results

Therapeutics: 5195

Respiratory Therapy: 481

Extracorporeal Membrane Oxygenation: 1725

Operative Surgical Procedures: 4

Extracorporeal Circulation: 1748

Extracorporeal Membrane Oxygenation: 1725

Experts

1.	Firmin, Richard K: 11 articles (08/2007 - 07/2003)
2.	Peek, Giles J: 9 articles (09/2008 - 07/2003)
3.	Ko, Wen-Je: 9 articles (08/2008 - 02/2002)
4.	Chen, Yih-Sharng: 7 articles (08/2008 - 02/2002)
5.	Huang, Shu-Chien: 6 articles (08/2008 - 01/2003)
6.	Tiruvoipati, Ravindranath: 5 articles (09/2008 - 07/2005)
7.	Lin, Fang-Yue: 5 articles (01/2006 - 02/2002)
8.	Schaible, Thomas: 4 articles (07/2008 - 06/2007)
9.	Kilian, A Kristina: 4 articles (07/2008 - 06/2007)
10.	Neff, K Wolfgang: 4 articles (07/2008 - 06/2007)

Related Diseases

1.	Respiratory Insufficiency (Respiratory Failure) 07/01/1996 - "We then present our experience from the past 11 years in the most invasive, yet successful, therapy for acute respiratory failure-extracorporeal membrane oxygenation (ECMO)" 01/01/2006 - "While extracorporeal membrane oxygenation is proven to result in improved outcome when compared to conventional ventilation in neonates with severe respiratory failure, there is currently no good evidence from randomised controlled trials to compare these managements for important clinical outcomes in adults, although evidence from case series is promising" 01/01/2008 - "AUTHORS' CONCLUSIONS: A policy of using ECMO in mature infants with severe but potentially reversible respiratory failure results in significantly improved survival without increased risk of severe disability" 01/01/2002 - "REVIEWER'S CONCLUSIONS: A policy of using ECMO in mature infants with severe but potentially reversible respiratory failure would result in significantly improved survival without increased risk of severe disability amongst survivors" 12/01/1997 - "CONCLUSIONS: We conclude that AVCO2R in a simple arteriovenous shunt is a less complicated technique than extracorporeal membrane oxygenation and is capable of total CO2 removal that allows a significant reduction in the minute ventilation and peak airway pressure during severe respiratory failure." Get all the results and reference details, order at left...
2.	Diaphragmatic Hernia 04/01/2002 - "1) To define the best outcome of severe Congenital Diaphragmatic Hernia (CDH); 2) to critically evaluate deaths in order to identify possible criteria of exclusion from ECMO; and 3) to identify CDHs which could benefit from ECMO" 09/01/2000 - "Open fetal surgery has proven too invasive to be justified for the treatment of diaphragmatic hernia, and progress in postnatal therapy (including ECMO) has dramatically improved the neonatal outcome in all but a severe subgroup of patients" 03/01/1995 - "This report suggests that stabilization of the intrauterine to extrauterine transitional circulation combined with a respiratory care strategy that avoids pulmonary overdistension, takes advantage of inherent biological cardiorespiratory mechanics, and very delayed surgery for congenital diaphragmatic hernia results in improved survival and decreases the need for extracorporeal membrane oxygenation (ECMO)" 12/01/1990 - "Our review demonstrates that ECMO improved survival significantly in infants with congenital diaphragmatic hernia who had a "poor prognosis" by the criteria of Bohn et al. We recommend consideration of ECMO for all infants with congenital diaphragmatic hernia for whom maximal medical therapy has failed." 03/01/1993 - "In addition to ECMO, pharmacologic therapy, fetal surgery, lobar transplant, and ventilatory management research show promising results for treatment of the infant with a congenital diaphragmatic hernia." Get all the results and reference details, order at left...
3.	Pulmonary Hypertension (Ayerza Syndrome) 05/01/1996 - "However, a second course of ECMO may be beneficial in a select group of infants when recurrent persistent pulmonary hypertension develops" 04/01/1995 - "We describe a case of PPHN in which neither inhaled NO nor ECMO was effective in reversing pulmonary hypertension" 11/01/1994 - "Inhaled NO may be effective in neonates with hypoplastic lungs who have recurrent episodes of pulmonary hypertension after ECMO, even if they were previously unresponsive." 01/01/1994 - "Where persistent pulmonary hypertension is a complicating problem the improved oxygenation resulting from the use of ECMO has a therapeutic role" 05/01/2004 - "Factors that improved the odds of survival were initiation of ECMO in theatre (64% survival (30 of 47)) rather than the cardiac intensive care unit (29% survival (10 of 34)) and initiation of ECMO for reactive pulmonary hypertension" Get all the results and reference details, order at left...
4.	Anoxia (Hypoxia) 06/01/1995 - "It is concluded that hypoxemia in CDH can be treated successfully with NO inhalation when conventional treatment fails, and it may in some cases prove to be an alternative to ECMO." 11/01/1997 - "Both interventions reversed hypoxemia, but ECMO did so to a greater degree, and only ECMO improved hypercarbia" 12/01/1992 - "Rescue therapy with continuous negative pressure is effective in infants with refractory hypoxemia and may be considered before referral for extracorporeal membrane oxygenation." 04/01/1999 - "Therefore, it is expected that the increased cardiac function may improved, and that the survival rate of the patients with retarded cardiac function due to severe hypoxemia may increase by proximal placement of the arterial cannula during V-A ECMO." 06/01/1990 - "2. In group 2 hypoxia and hypercapnea were improved by pumpless ECMO, and 4 in 9 lived for 24 hours" Get all the results and reference details, order at left...
5.	Heart Failure 09/01/1994 - "Extracorporeal membrane oxygenation (ECMO) has dramatically improved the survival of neonates with life-threatening respiratory and cardiac failure" 02/01/2005 - "Extracorporeal membrane oxygenation (ECMO) therapy has significantly improved outcome in the newborn, pediatric, and adult patient in respiratory and cardiac failure" 11/01/2007 - "Extracorporeal membrane oxygenation (ECMO) has been shown to improve outcomes in neonatal patients with respiratory and/or cardiac failure" 04/01/2002 - "The patient improved after 8 days of ECMO in addition to use of an intraaortic balloon pump and administration of inotropic agents for profound heart failure" 06/01/1993 - "This procedure may be helpful in selected patients receiving extracorporeal membrane oxygenation for myocardial failure with evidence of increased left atrial pressure as a result of increased ventricular pressure." Get all the results and reference details, order at left...
342 Diseases and 1725 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Nitric Oxide (Nitrogen Monoxide)
2.	Oxygen
3.	Heparin (Liquaemin)
4.	glucuronyl glucosamine glycan sulfate (Vessel)
5.	Steroids
6.	Lactic Acid
7.	Factor VIIa (Activated Factor VII)
8.	recombinant FVIIa (rFVIIa)
9.	Tea
10.	simendan (Levosimendan)
171 Drugs and Important Bio-Agents and 330 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Extracorporeal Membrane Oxygenation (ECMO)
2.	Transplants (Transplant)
3.	Resuscitation
4.	Heart Transplantation (Grafting, Heart)
5.	Oxygenators
97 Therapies and Procedures and 945 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>